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Abstract
Introduction: Brain derived neurotrophic factor (BDNF) has been implicated in memory, learning, and neurodegenerative
diseases. However, the relationship of BDNF with cardiometabolic risk factors is unclear, and the effect of exercise training
on BDNF has not been previously explored in individuals with type 2 diabetes.
Methods: Men and women (N = 150) with type 2 diabetes were randomized to an aerobic exercise (aerobic), resistance
exercise (resistance), or a combination of both (combination) for 9 months. Serum BDNF levels were evaluated at baseline
and follow-up from archived blood samples.
Results: Baseline serum BDNF was not associated with fitness, body composition, anthropometry, glucose control, or
strength measures (all, p.0.05). Similarly, no significant change in serum BDNF levels was observed following exercise
training in the aerobic (21649.4 pg/ml, CI: 24768.9 to 1470.2), resistance (22351.2 pg/ml, CI:25290.7 to 588.3), or
combination groups (2827.4 pg/ml, CI: 23533.3 to1878.5) compared to the control group (22320.0 pg/ml, CI: 25750.8 to
1110.8). However, reductions in waist circumference were directly associated with changes in serum BDNF following
training (r = 0.25, p = 0.005).
Conclusions: Serum BDNF was not associated with fitness, body composition, anthropometry, glucose control, or strength
measures at baseline. Likewise, serum BDNF measures were not altered by 9 months of aerobic, resistance, or combination
training. However, reductions in waist circumference were associated with decreased serum BDNF levels. Future studies
should investigate the relevance of BDNF with measures of cognitive function specifically in individuals with type-2
diabetes.
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of whether the higher rate of cognitive impairments in diabetes
may be in part mediated by low BDNF levels [7]. Similar findings
have been reported in non-diabetic individuals in which lower
serum BDNF levels have been associated with insulin resistance
and higher body fat [8].
Conversely, other studies have found the opposite relationship,
noting elevated serum BDNF levels in individuals with type 2
diabetes [9]. In addition, higher serum and plasma BDNF levels
have been associated with cardiometabolic risk factors [9–11], and
specifically serum BDNF has been inversely correlated with total
daily energy expenditure [12] and aerobic fitness [13,14].
Fujinami et al. [6] found that serum BDNF was directly associated
with fasting insulin and homeostatic model assessment of insulin

Introduction
Brain derived neurotrophic factor (BDNF) is a protein encoded
by the BDNF gene. It is a neutrophin (e.g., growth factor) involved
in neuronal plasticity, differentiation, and survival in the central
and peripheral nervous system [1,2]. Low levels of BDNF have
been associated with learning/cognitive dysfunction [2], depression [3], neurodegenerative conditions [4], and mortality [5].
BDNF has been studied in various populations; however, the
clinical significance of BDNF levels remains unclear in individuals
with type 2 diabetes. Previous studies have found that serum [6]
and plasma [7] BDNF levels are lower in individuals with type 2
diabetes compared to non-diabetic individuals, posing the question
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asked to maintain their current activity during the 9-month study
period. Accordingly, the compliance of the control group was
assessed with step counters to confirm continued sedentary
behavior. All exercise sessions were supervised by study staff in
our exercise training laboratory.
The exercise intensity for aerobic exercise training was 50% to
80% of maximal oxygen consumption. We estimated that
150 minutes of physical activity per week (consistent with public
health recommendations) is equivalent to approximately 10 to
12 kcals/kg of body weight per week (KKW) (5). The selected dose
of exercise for the aerobic group was 12 KKW and 10 KKW for
the combination exercise group. Participants were weighed weekly
to calculate the energy expenditure target for each participant.
American College of Sports Medicine equations were used to
estimate caloric expenditure rate and time required for each
session (1).
Participants in the resistance training group exercised 3 days per
week with each session consisting of 2 sets of 4 upper body
exercises (bench press, seated row, shoulder press and lat pull
down), 3 sets of 3 leg exercises (leg press, extension, and flexion),
and 2 sets of each abdominal crunches and back extensions. Each
set of resistance exercise consisted of 10 to 12 repetitions.
Individuals in the combination exercise group had two sessions
per week with each session consisting of 1 set of each of the 9
resistance exercises. The weight lifted on each exercise was
progressively increased once the participant was able to complete
12 repetitions for each set of exercises on 2 consecutive exercise
sessions.
The control group was unblinded after a significant number of
participants (17.1%) had an increase in HbA1C level of 1.0% or
higher. With the recommendation of the data safety monitoring
board, randomization into the control group was discontinued (5).
Thus, fewer participants completed the study in the control group
compared to the other randomization groups.

resistance in women but not men in a Japanese sample (N = 112)
of individuals with type 2 diabetes. It has been proposed that
BDNF may be elevated in individuals with type 2 diabetes as a
compensatory mechanism to provide additional neuroprotection
due to the presence of chronic hyperglycemia and other
cardiometabolic risk factors [9,15].
Exercise training increases fitness [16], improves glycemic
control [16,17], and reduces body fat [16,17] in individuals with
type 2 diabetes. Specifically, the combination of aerobic and
resistance training (combination training) has been shown to be
the most effective in improving glycemic control compared to
aerobic or resistance training alone [16–18]. Previous data on the
effect of exercise training on BDNF levels is unclear with some
evidence of higher plasma [19] and serum [20] BDNF levels
following aerobic training while other studies have found no
significant change in BDNF levels following aerobic [21–24] or
resistance training [21]. However, studies in this area have
important limitations/considerations such as small sample size
[19,22], no control group [19], were conducted in young healthy
individuals [19,21,24,25] or subject populations with specific
neurological conditions [20,26]. To our knowledge, the effects of
exercise training or a comparison of different training modalities
(aerobic, resistance, or a combination of both) on BDNF levels
have not been explored in individuals with type 2 diabetes in a
large randomized trial. The objectives of the present study were to
(1) evaluate the association between cardiometabolic risk factors
(fitness, anthropometry, body composition, and glucose control)
and strength variables on baseline serum BDNF levels; and (2) to
test the effects of aerobic, resistance, and combination exercise
training on serum BDNF levels in individuals with type 2 diabetes.

Methods
The full methodology of the exercise training program used in
the Health Benefits of Aerobic and Resistance Training in
Individuals with Type 2 diabetes (HART-D) has been reported
in the main outcomes paper [16]. HART-D was a 9 month
exercise study comparing the effects of aerobic training, resistance
training, or a combination of both on HbA1C in men and women
with type 2 diabetes. The primary outcome measure of this
ancillary study is the change in serum BDNF levels following
exercise training. From the parent HART-D study of 262
sedentary (30–75 years) adults with type 2 diabetes presenting
with an HbA1C of 6.5% to 11.0%, serum BDNF values were
examined in a subset of controls and adherent exercisers (n = 168)
from which a total of 150 participants were included in the final
analysis. A consort diagram is shown in Figure 1. Notable
exclusion criteria for the HART-D trial included a body mass
index (BMI).48 kg/m2, blood pressure 160/100 mmHg or
higher, fasting triglycerides 500 mg/dL or higher, use of an
insulin pump, urine protein greater than 100 mg/dL, history of
stroke, advanced neuropathy, retinopathy, or any serious medical
condition that prevented adherence to the study protocol or was a
contraindication for exercise training. The institutional review
board at Pennington Biomedical Research Center approved the
protocol annually and all participants provided written informed
consent before initiating the any of the study protocols.

Exercise Testing
Exercise testing was performed on a treadmill (Trackmaster
425, Newton Kansas) with respiratory gasses analyzed using a
True Max 2400 Metabolic Measurement Cart (Parvomedics, Salt
Lake City Utah). Participants self-selected a brisk walking pace at a
grade of 0% for 2 minutes, and then the grade was increased by
2% every 2 minutes until exhaustion. Fitness data are reported in
absolute VO2 peak (L/min), relative VO2 peak (mL?kg21?min21),
and treadmill test duration (min). All muscular strength assessments were performed using a Biodex System 3 dynamometer
(Biodex Medical Systems, Shirley, New York). Total work was
determined as the work accomplished over 30 repetitions of
maximal effort.

Body Composition and Anthropometry Testing
Body composition and percent body fat were determined using
dual-energy X-ray absorptiometry scans performed using the
QDR 4500A whole body scanner (Hologic Inc., Bedford,
Massachusetts). Weight was measured with on a calibrated
electronic scale (GSE scale Systems, Novi Michigan). Waist
circumference was measured by Gulick tape midway between
the inferior border of the rib cage and the superior aspect of the
iliac crest at the end of normal expiration.

Study Design
Blood Samples

Participants were randomized to one of four groups: a nonexercise control group, aerobic training only (aerobic), resistance
training only (resistance), or a combination of resistance and
aerobic training (combination). The non-exercise control group
was offered weekly stretching and relaxation classes and were
PLOS ONE | www.plosone.org

Serum BDNF levels were measured by the Pennington
Biomedical Research Center Clinical Research Laboratory at
baseline and follow-up from archived blood samples stored at 280
degrees Celsius. Serum BDNF levels were analyzed using a
2

August 2012 | Volume 7 | Issue 8 | e42785

Exercise Training Modality and BDNF

Figure 1. Consort diagram.
doi:10.1371/journal.pone.0042785.g001

Table 1. Baseline Characteristics.

Control (N = 23)

Aerobic (N = 40)

Resistance (N = 44)

Combination (N = 43)

69.6 (16)

57.5 (23)

52.3 (23)

55.8 (24)

White

52.2 (12)

62.5 (25)

63.6 (28)

65.1 (28)

Black

43.5 (10)

37.5 (15)

34.1 (15)

27.9 (12)

Hispanic/Other

4.4 (1)

0 (0)

2.3 (1)

7.0 (3)

Age (yr)

58.4 (8.7)

54.2 (7.3)

58.8 (8.7)

56.7 (8.2)

Weight (kg)

93 (19.4)

97.1 (19.9)

97.3 (17.2)

101.0 (21.4)

BMI (kg/m2)

33.3 (6.3)

33.9 (6.4)

33.8 (5.4)

35.4 (6.5)

Waist circumference (cm)

106.9 (13.3)

109.6 (14.7)

111.6 (12.6)

115.0 (15.4)

Body fat (%)

37.2 (6.9)

36 (7.7)

36.5 (7.9)

37.8 (7.1)

Systolic blood pressure (mmHg)

124.7 (13.9)

123 (11)

126 (13.0)

129.5 (12.3)

Diastolic blood pressure (mmHg)

75.5 (7.8)

76.2 (9.4)

74.2 (8.3)

74.7 (7.8)

Hemoglobin A1C

7.8 (1.7)

7.2 (1.1)

7.2 (1.0)

7.1 (1.1)

Absolute VO2peak (L/min)

1.7 (0.5)

2.0 (0.5)

1.9 (0.5)

1.9 (0.5)

18.3 (4.1)

21.1 (5.3)

19.9 (4.5)

19.3 (3.7)

10.6 (2.3)

11.3 (3.2)

10.5 (2.7)

10.7 (2.4)

Flexion

1.2 (0.3)

1.1 (0.3)

1.1 (0.3)

1.1 (0.4)

Extension

1.2 (0.2)

1.1 (0.3)

1.3 (0.4)

1.2 (0.4)

Diabetes duration (yrs)

7.0 (5.4)

7.9 (6.0)

8.0 (5.6)

6.4 (3.6)

Serum BDNF (pg/ml)

16928.1 (6781.7)

18870.4 (8153.5)

17509.2 (8679.1)

18413.3 (7798.2)

Diabetes medication % (n)

Female % (n)
Ethnicity % (n)

Relative VO2

peak

(mL?kg21?min21)

Treadmill test duration (min)
Muscular work (Nm)

100.0 (23)

97.5 (39)

100.0 (44)

100.0 (43)

Biguanide %(n)

60.9 (14)

70.0 (28)

59.1 (26)

72.09 (31)

Sulfonylureas %(n)

30.4 (7)

25.0 (10)

25.0 (11)

23.26 (10)

Thiazolidnediones %(n)

17.4 (4)

25.0 (10)

18.2 (8)

16.3 (7)

Combo Class % (n)

21.7 (5)

15.0 (6.0)

18.2 (8)

18.6 (8)

Insulin % (n)

26.1 (6)

15.0 (6)

15.9 (7)

20.9 (9)

doi:10.1371/journal.pone.0042785.t001
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Table 2. The association between baseline serum BDNF levels (quartiles) and cardiometabolic risk factors.

Q1 (,8603 pg/ml)

Q2 (8604–19922
pg/ml)

Q3 (19923–28747
pg/ml)

Q4 (.28747 pg/ml)

N = 38

N = 37

N = 38

N = 37

P-Trend

Age (yrs)

56.2 (6.9)

56.4 (9.3)

58.3 (8.3)

56.7 (8.8)

0.56

Diabetes duration
(yrs)

8.3 (5.5)

6.4 (4.8)

7.7 (5.3)

6.9 (5.1)

0.44

Relative VO2 peak
(mL?kg21?min21)

20.1 (3.9)

19.9 (5.7)

19.0 (4.3)

20.3 (4.1)

0.53

Absolute VO2 peak
(L/min)

2.0 (0.5)

1.9 (0.6)

1.9 (0.4)

1.9 (0.6)

0.90

Treadmill test duration
(min)

11.4 (2.5)

10.9 (3.1)

10.5 (2.6)

10.3 (2.4)

0.06

Body mass index (BMI)

34.7 (5.6)

34.2 (5.9)

35.0 (5.8)

32.9 (7.1)

0.35

Waist circumference
(cm)

113.8 (14.6)

109.7 (13.6)

112.1 (12.9)

109.7 (16.0)

0.34

Body fat (%)

36.4 (6.2)

38.0 (8.1)

38.5 (7.9)

34.4 (6.8)

0.35

Systolic blood
pressure (mmHg)

127.8 (12.2)

124.5 (13.1)

125.6 (11.5)

126.2 (13.8)

0.68

Diastolic blood
pressure (mmHg)

74.8 (10.4)

75.2 (8.0)

74.6 (7.6)

75.7 (7.4)

0.74

HbA1C (%)

7.4 (1.1)

7.0 (1.3)

7.6 (1.4)

7.1 (1.1)

0.90

Work flexion (Nm)

1032.7 (436.8)

975.2 (492.0)

970.0 (553.1)

1038.3 (562.6)

0.98

Work extension (Nm)

2506.0 (790.1)

2392.8 (990.5)

2250.5 (946.4)

2411.6 (957.9)

0.52

Multiple linear regression was used to test the trend of baseline BDNF. P-trend ,0.05 was the criteria for statistical significance.
doi:10.1371/journal.pone.0042785.t002

An analysis of covariance (ANCOVA) was used to determine
the effect of exercise modality on serum BDNF levels with baseline
value, age, sex, duration of diabetes, and ethnic group entered as
covariates with outliers removed (N = 150). Results are presented
as adjusted least square means with 95% confidence intervals
(CIs). In addition, we performed the same analysis in all
participants (outliers included) (N = 168). Spearman correlations
were used to determine the association between the change in
serum BDNF following exercise training and fitness, body
composition, anthropometry, glucose control, and strength measures in exercisers only (N = 127). A p value of ,0.05 was used as
the criteria for statistical significance for all analyses.

Chemkine BDNF sandwich enzyme immunoassay (Milpore,
Billerica, MA). The sensitivity of the assay was 67.8 pg/mL with
an inter-assay variation of 68.5% and an intra-assay variation of
63.5%. All samples for serum BDNF at baseline and follow-up
were run on the same analysis plate in order to eliminate interassay variation between pre- and post-intervention pairs. HbA1C
was evaluated from venipuncture, and samples were run on
Beckman Coulter Synchron LX automated analyzer (Fullerton,
CA). At baseline and follow-up, blood samples were collected and
processed after an overnight fast.
HART-D had separate intervention and assessment teams, and
all assessment staff were blinded to participant randomization.
The clinical testing and exercise training laboratories were in
separate buildings, and participants were reminded frequently not
to disclose their group assignment to assessment staff.

Results
Demographic data are presented in Table 1. The study sample
had a mean (SD) age of 57.9 (8.3) yrs; a mean weight of 97.6 (19.5)
kg; a mean BMI of 34.2 (6.1) kg/m2; was 57% female; and was
ethnically diverse as approximately 35% of our study sample was
Black. The average duration of diabetes in the sample was 7.3 yrs.
(5.2), and approximately 99% of the population was currently
taking diabetes related medication. No significant differences
between randomization groups were present at baseline. Additionally, no significant differences in baseline serum BDNF levels
between men (18034.5 pg/ml) and women (18048.0 pg/ml)
(p = 0.991) or Blacks (18744.8 pg/ml) and Whites (17591.1 pg/
ml) (p = 0.407) were observed.

Statistical Analysis
All data was analyzed using SAS version 9.1 (SAS Institute Inc,
Cary, North Carolina). The final analysis of the present study was
performed in adherent participants (70% adherent to exercise
intervention consistent with the definition used in our main
outcome paper [16]) with outliers removed. Outliers were defined
as participants who were more than 95% above the median value
for the change in serum BDNF levels following exercise training,
and were removed from the final analysis. A one-way analysis of
variance (ANOVA) was used to compare baseline characteristics
between groups of continuous variables, and a chi-squared test (x2)
was used to compare baseline characteristics between categorical
variables. Multiple linear regression was used to test the trend of
baseline serum BDNF levels across quartiles of fitness, body
composition, anthropometry, glucose control, and strength measures.
PLOS ONE | www.plosone.org

Serum BDNF levels at baseline across quintiles of
cardiometabolic risk factors
Serum BDNF levels across quartiles of fitness, body composition, anthropometry, glucose control, and strength measures are
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shown in Table 2. Overall, no significant associations between
these factors and baseline serum BDNF levels were observed (all,
p.0.05). However, the trend for lower serum BDNF levels across
quartiles of treadmill test duration approached significance (ptrend = 0.06). When analyses were performed separately in men
and women, similar results were observed.

Table 3. Spearman correlations for the change in BDNF
following exercise training with changes in cardiometabolic
risk factors in exercisers (N = 127).

r
D Relative VO2

The effects of exercise training modality on serum BDNF
levels
The effects of exercise modality on serum BDNF levels are
shown in Figure 2. No significant change in serum BDNF levels
was observed following exercise training in the aerobic
(21649.4 pg/ml, CI: 24768.9 to 1470.2), resistance
(22351.2 pg/ml, CI:25290.7 to 588.3), or combination groups
(2827.4 pg/ml, CI: 23533.3 to1878.5) compared to the control
group (22320.0 pg/ml, CI: 25750.8 to 1110.8). Similarly, when
the same analysis was performed with outliers included (N = 168),
no significant change was observed in serum BDNF levels between
the aerobic (2432.9 pg/ml, CI: 2432.9 pg/ml, CI: 24413.9 to
3548.2), resistance (2827.9 pg/ml, CI: 24601.9 to 2946.2), and
combination groups (21912.5 pg/ml, CI: 25257.3 to 1432.2)
compared to the control group (23864.1 pg/ml, CI: 28487.3 to
2759.2).

(mL?kg

peak

?min

21

)

(L/min)

p-value

0.02

0.84

0.03

0.75

D Treadmill test duration (min)

20.11

0.21

D Body mass index (BMI)

0.10

0.28

D Waist circumference (cm)

0.25

0.005

D Body fat (%)

0.10

0.26

D Systolic blood pressure (mmHg)

20.07

0.39

D Diastolic blood pressure (mmHg)

20.02

0.81

D HbA1C (%)

0.02

0.86

D Work flexion (Nm)

20.02

0.85

D Work extension (Nm)

20.01

0.94

doi:10.1371/journal.pone.0042785.t003

of aerobic, resistance, and combination training on serum BDNF
levels in individuals with type 2 diabetes.
Currently, data are limited that examine the implications of
cardiometabolic risk factors on BDNF in individuals with type 2
diabetes. Suwa et al. [9] found that in a small sample (n = 24) of
newly diagnosed females with type 2 diabetes that serum BDNF
levels were elevated compared to healthy women (n = 7). The
authors further reported a direct relationship between BMI
(r = 0.54, p = 0.006), body fat (r = 0.55, p = 0.004), triglycerides
(r = 0.47, p = 0.019), fasting blood glucose (r = 0.44, p = 0.032),
and HOMA-IR (r = 0.51, p = 0.011) with serum BDNF values.
Similarly, Krabbe et al. [7] found that plasma BDNF levels were
the lowest in obese individuals with type 2 diabetes compared to
individuals with impaired glucose tolerance and normal glucose
tolerance.
In the present study, no associations were found at baseline
between fitness, anthropometry, body composition, strength, or
glucose control measures and serum BDNF levels in individuals
with type 2 diabetes. However, the relationship between serum
BDNF levels and longer treadmill test duration approached
significance. Our results are supported by data from Fujinami et
al. [6] who found that serum BDNF was not associated with age,
BMI, blood pressure, diabetes duration, or HbA1C in Japanese
men and women with type 2 diabetes. Differences between our
study and previous studies finding an association between BDNF
levels and cardiometabolic risk factors in individuals with type-2
diabetes may be due to the differences in the type of sample
analyzed for BDNF (plasma vs. serum), differences in study
population (HART-D: 34% Black), and possible differences in the
use of diabetes medications.
Several studies have demonstrated an increase in serum BDNF
levels following acute exercise [27–31]; however, the effects of
chronic exercise on BDNF remain unclear. Zoladz et al. [19]
found an increase in plasma BDNF levels in young men following
5 months of moderate intensity aerobic exercise training.
Castellano et al. [20] found that serum BDNF levels significantly
increased in individuals with multiple sclerosis following 4 weeks of
aerobic exercise training but returned near baseline levels
following 8 weeks of training. Erickson et al. [23] conducted a
large randomized controlled trial in older adults without dementia
and found no significant change in BDNF following 6 months of
aerobic exercise. The only study investigating the effects of aerobic

Correlations of changes in serum BDNF levels with
changes in cardiometabolic risk factors following
exercise training
Spearman correlations for change in serum BDNF levels
following exercise training (exercisers only) with cardiometabolic
risk factors are shown in Table 3. Change in serum BDNF levels
following exercise training was directly associated with waist
circumference (r = 0.25, p = 0.005) but not associated with changes
in systolic blood pressure, diastolic blood pressure, weight, fitness,
or strength measures (p.0.05).

Discussion
The primary finding from the present study was cardiometabolic risk factors were not associated with serum BDNF levels at
baseline in individuals with type 2 diabetes. Furthermore, 9
months of aerobic, resistance, or combination training did not
alter serum BDNF levels compared to control participants, but
reductions in waist circumference were associated with decreased
serum BDNF following exercise training. To our knowledge, this is
the first large randomized controlled study comparing the effects

Figure 2. The effect of exercise training modality on serum
BDNF levels. Results are presented as adjusted least square means
with 95% confidence intervals. The statistical model is adjusted for
baseline value, age, sex, duration of diabetes, and ethnic group.
doi:10.1371/journal.pone.0042785.g002

PLOS ONE | www.plosone.org
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versus resistance training was conducted by Schiffer et al. [21],
which found no significant change in plasma BDNF following
aerobic or resistance exercise in healthy young adults.
The present study is the first to our knowledge to evaluate the
effects of exercise training on serum BDNF specifically in
individuals with type 2 diabetes or to directly compare the effect
of different exercise modalities in a large randomized trial. We
found no significant change in serum BDNF following aerobic,
resistance or combination exercise training compared to control
participants. Additionally, we found that reductions in waist
circumference following exercise training in exercisers were
positively associated with serum BDNF levels, suggesting that
reductions in central adiposity may be involved in the regulation of
BDNF. The physiologic importance of these findings on cognitive
function should be addressed in future investigations since
cognitive measures were not collected in HART-D. Changes in
fitness, body composition, glucose control, and strength measures
were not associated with changes in serum BDNF following
exercise training in the present study.
The strengths of this investigation include a randomized study
design with a large diverse study population. Additionally, all
exercise training sessions were supervised by study staff, controlled
for caloric expenditure, and all exercise groups exercised for a
similar amount of time. Limitations of the present study are that it
is a post-hoc analysis from archived blood samples, and we did not
collect any measures of cognitive function. Last, since blood
samples were collected at only baseline and follow-up, we cannot

evaluate the time course of the changes in serum BDNF during the
exercise intervention.
In conclusion, the results of the present study found that serum
BDNF levels at baseline were not associated with fitness, body
composition, anthropometry, glucose control, and strength measures in individuals with type 2 diabetes. In addition, no significant
change in serum BDNF levels was observed compared to control
participants following 9 months of exercise irrespective of training
modality. Future research should evaluate the relationship
between serum BDNF levels with memory and cognitive function
specifically in individuals with type 2 diabetes, and the physiological mechanisms responsible for the association between exercise
training related changes in central adiposity and serum BDNF
levels.
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